September 25, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

GRAIL's Galleri cancer blood test moves closer to FDA approval after an advisory panel found benefits outweigh risks, despite a near-split vote on efficacy
Wearables draw $4.1B in investment this year, nearing the 2021 peak as Whoop raises $575M and Oura preps a potential $16B public listing
Precision Neuroscience closes a $250M Series D, bringing total funding to $430M as its FDA-cleared brain-computer interface moves toward commercial use

Today's episode is brought to you by AIIR — a modern communications and experiential agency for health, wellness, fitness, and performance brands. From earned media to events and creator-led campaigns, AIIR helps companies sharpen their story, earn attention, and build trust that compounds. Visit https://aiir.agency to learn more.

More from Fitt:

Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital.

Subscribe to our newsletter → insider.fitt.co/subscribe

Work with our recruiting firm → https://talent.fitt.co/

Follow us on Instagram → https://www.instagram.com/fittinsider/

Follow us on LinkedIn → linkedin.com/company/fittinsider

Reach out → insider@fitt.co

Wearables Funding Surges, Brain Tech Raises $250M, GRAIL Nears FDA Decision

Fitt Insider

Wearables Funding Surges, Brain Tech Raises $250M, GRAIL Nears FDA Decision